Frederic Destaillats

This inventor holds 17 USPTO granted patents and 31 published patent applications, plus 1 CIPO patent and 19 EPO patents. Top assignees: Societe Des Produits Nestle S.a., Nestec S.a., Beth Israel Deaconess Medical Center, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frederic Destaillats. Retrieved from https://idiyas.com/inventor/frederic-destaillats

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 31)

% Patents Active = 88.2

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 19 (Patent Applications = 37)

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 12(Granted Patents)

Company Filing History:

9 out of 1,281

Societe Des Produits Nestle S.a.

Beth Israel Deaconess Medical Center, Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527761 - Mixed triglycerides (2026-01-20),

2. 12290201 - System for assisting the personalized preparation of infant formula including a connected electronic scale (2025-05-06),

3. 11980215 - Synthetic milk compositions for infants less than three months old and for infants and children more than three months for ensuring optimal growth and preventing obesity (2024-05-14),

4. 11357252 - Synthetic milk compositions for optimal growth and development and prevention of obesity in male and female infant and children (2022-06-14),

5. 11357249 - Synthetic milk compositions comprising n-6 eicosatrienoic acid and polar lipids for infants younger and older than three months for healthy establishment of cognitive function (2022-06-14),

6. 11357248 - Synthetic milk compositions for infants less than three months old and for infants and children more than three months for ensuring optimal growth and preventing obesity (2022-06-14),

7. 11278047 - Lipid composition for use in infants and young children for promoting gut comfort and optimal fat and calcium absorption (2022-03-22),

8. 11261401 - Synthesis of 1,3-olein-2-palmitin (OPO) (2022-03-01),

9. 10820616 - Infant formula system with adaptive levels of human milk oligosaccharides (HMOs) (2020-11-03),

10. 10201244 - Packaging system for infant nutritional composition with dosing devices (2019-02-12),

11. 10039742 - Sn-2-monoacylglycerols and lipid malabsorption (2018-08-07),

12. 9826767 - Infant formula with a low content of MCFAS in specific proportions and a relatively high content of unsaturated fatty acids, and its use in promoting the healthy establishment of cognitive function in infants (2017-11-28),

13. 9687462 - Sn-2-monoacylglycerols and lipid malabsorption (2017-06-27),

14. 9522132 - Sn-2-monoacylgycerols and lipid malabsorption (2016-12-20),

15. 9034917 - Sn-2-monoacylglycerols and lipid malabsorption (2015-05-19),

Title: Inventor Frederic Destaillats

Introduction: Frederic Destaillats is a renowned inventor based in Servion, Switzerland, known for his groundbreaking contributions to the field of innovations and patents.

Latest Patents: Frederic Destaillats holds several patents in various industries, including energy-efficient technologies, sustainable materials, and environmental solutions.

Career Highlights: With a career spanning over two decades, Destaillats has worked with leading research institutions and universities to develop cutting-edge inventions that have had a significant impact on society.

Collaborations: Throughout his career, Frederic Destaillats has collaborated with top companies, innovative startups, and talented inventors to bring his ideas to life and create meaningful change in the world.

Conclusion: Frederic Destaillats continues to be a driving force in the world of inventions, constantly pushing the boundaries of what is possible and shaping the future with his innovative solutions.

Profile summary based on public USPTO records.